Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Tucson, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Arizona Oncology Associates - Rudasill
mi
from
Tucson, AZ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Escondido, CA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Southwest Cancer Care
mi
from
Escondido, CA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Denver, CO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Rocky Mountain Cancer Center
mi
from
Denver, CO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Hudson, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Florida Cancer Institute - New Hope
mi
from
Hudson, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Melbourne, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Melbourne Internal Medical Associates
mi
from
Melbourne, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Ocoee, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Florida Institute of Research, Medicine & Surgery
mi
from
Ocoee, FL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Niles, IL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Cancer Care & Hematology Specialists of Chicagoland
mi
from
Niles, IL
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Carmel, IN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Central Indiana Cancer Centers
mi
from
Carmel, IN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Westminister, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Alliance Hematology Oncology
mi
from
Westminister, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Minneapolis, MN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Minnesota Oncology Hematology, P.A.
mi
from
Minneapolis, MN
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Columbia, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Missouri Cancer Associates
mi
from
Columbia, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Columbia, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Maryland Oncology Hematology PA
mi
from
Columbia, MD
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Overland Park, KA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Kansas City Cancer Center, LLC
mi
from
Overland Park, KA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
St. Joseph, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
St. Joseph Oncology, INC
mi
from
St. Joseph, MO
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Henderson, NV
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Comprehensive Cancer Care Centers of Nevada
mi
from
Henderson, NV
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Morristown, NJ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
New York, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Ruth Oratz MD
mi
from
New York, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Rochester, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Interlakes Oncology/Hematology PC
mi
from
Rochester, NY
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Raleigh, NC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Dayton, OH
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Dayton Clinical Research
mi
from
Dayton, OH
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Vancouver, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Northwest Cancer Specialists-134th St.
mi
from
Vancouver, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Kingston, PA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Medical Oncology Associates
mi
from
Kingston, PA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Greenville, SC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Amarillo, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Austin, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Bedford, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology Medical City Dallas
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Abilene, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology-Abilene
mi
from
Abilene, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology- Sammons CC
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Denton, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology- Denton South
mi
from
Denton, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Austin, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology - Baylor Charles A. Simmons Cancer Center
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Sherman, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology - Sherman
mi
from
Sherman, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Sugar Land, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Tyler, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology-Tyler
mi
from
Tyler, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Beaumont, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center
mi
from
Beaumont, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
San Antonio, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Waco, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology-Waco
mi
from
Waco, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Wichita Falls, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Texas Oncology Wichita Falls Texoma Cancer Center
mi
from
Wichita Falls, TX
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Norfolk, VA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Virginia Oncology Assoc.
mi
from
Norfolk, VA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Burien, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Highline Medical Oncology
mi
from
Burien, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Edmonds, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Pudget Sound Cancer Center
mi
from
Edmonds, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Kennewick, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Spokane, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Spokane, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Cancer Care Northwest
mi
from
Spokane, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Yakima, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Yakima Valley Memorial
mi
from
Yakima, WA
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
mi
from
Beckley, WV
Ixabepilone + Carboplatin Metastatic Breast Cancer
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Status: Archived
Updated: 1/1/1970
Raleigh Regional Cancer Center
mi
from
Beckley, WV
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors
A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors
Status: Archived
mi
from
Teaneck, NJ
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors
A Pilot, Phase II , Open Label, Nonrandomized, Multi- Center Study of [F 18]HX4 Positron Emission Tomography (PET) to Detect Hypoxia in Tumors
Status: Archived
Updated: 1/1/1970
Holy Name Medical Center
mi
from
Teaneck, NJ
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
A Phase II Study of Bortezomib, Liposomal Doxorubicin, Dexamethasone, and Cyclophosphamide in Patients With Multiple Myeloma Relapsing Within 12 Months of Autologous Stem Cell Transplant
Status: Archived
mi
from
Scottsdale, AZ
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
A Phase II Study of Bortezomib, Liposomal Doxorubicin, Dexamethasone, and Cyclophosphamide in Patients With Multiple Myeloma Relapsing Within 12 Months of Autologous Stem Cell Transplant
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ